S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Momenta Pharmaceuticals Exercises Option to Acquire Novel Antibodies From AnaptysBio|
|Momenta Pharmaceuticals Reports Third Quarter 2014 Financial Results|
|Momenta Pharmaceuticals Announces Acceptance of a Clinical Trial Application in Europe for M923, a Biosimilar Version of Humira(R)|
|Momenta Pharmaceuticals Announces Abbreviated New Drug Application for Three-Times-a-Week Generic Copaxone Accepted for Review by FDA|
|Momenta Pharmaceuticals Announces Top-Line Part A Results From Phase 1/2 Trial of Necuparanib in Patients With Pancreatic Cancer|
|Momenta Pharmaceuticals' Necuparanib Receives Fast Track Designation From the FDA for the Treatment of Patients With Metastatic Pancreatic Cancer|
|Momenta Pharmaceuticals to Host 2014 R&D Day|
|Momenta Pharmaceuticals Announces Date of Third Quarter 2014 Financial Results Conference Call and Webcast|
|Momenta Pharmaceuticals to Webcast Presentation at Three Upcoming Investor Conferences|
|Momenta Pharmaceuticals to Webcast Presentation at 2014 Deutsche Bank BioFEST|
Click above to view more mutual fund data and stats for mnta - Momenta Pharmaceuticals Inc.